From: Outcome predictors in patients with temporal lobe epilepsy after temporal resective surgery
Characteristics | Number of patients (%)/Mean ± SD (range) |
---|---|
Total number | 94 |
Male | 50 (53.2%) |
Age at surgery, years | 26.06 ± 10.48 (4–56) |
Age at seizure onset, years | 14.94 ± 10.14 (1–55.3) |
   ≤ 18 | 67 (71.3%) |
   >18 | 27 (28.7%) |
Disease duration, months | 11.12 ± 8.56 (0.7–45.0) |
Side of surgery | Â |
 Left | 48 (51.1%) |
 Right | 46 (48.9%) |
Early appearance of GTCS | 57 (60.6%) |
 No | 37 (39.4%) |
 Yes | 57 (60.6%) |
Seizure frequency, monthly | Â |
 < 10 times | 71 (75.5%) |
 ≥ 10 times | 23 (24.5%) |
Preoperative intermittent EEG abnormality | Â |
 Unilateral | 71 (75.5%) |
 Bilateral | 23 (24.5%) |
Typical symptomatology | Â |
 Negative | 20 (21.3%) |
 Positive | 74 (78.7%) |
Consistency of resection site with ictal EEG initiation region | Â |
 No | 20 (21.3%) |
 Yes | 73 (77.77%) |
 Unkown | 1 (1.1%) |
Low-metabolic-activity regions in PET/CT | Â |
 Multiple | 69 (73.4%) |
 Single | 22 (23.4%) |
PET/CT not performed | 3 (3.2%) |
Intraoperative discharge range being within the resection range | Â |
 No | 17 (18.1%) |
 Yes | 77 (81.9%) |
Drug-resistant epilepsy | Â |
 No | 37 (39.4%) |
 Yes | 57 (60.6%) |
Postoperative EEG abnormalities | 39 (41.5%) |
Lesion location | Â |
 Mesial temporal lobe | 61 (64.9%) |
 Neocortical temporal lobe | 33 (35.1%) |